# Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant

> **NCT00135694** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 275 (actual)

## Conditions studied

- Hepatitis C
- Hepatitis C, Chronic
- Nonimmune Nonviral Causes of Liver Failure

## Interventions

- **DRUG:** calcineurin inhibitor-based immunosuppression
- **PROCEDURE:** liver transplant
- **DRUG:** corticosteroids
- **OTHER:** immunosuppression withdrawal

## Key facts

- **NCT ID:** NCT00135694
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 275 (ACTUAL)
- **Last updated:** 2019-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00135694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00135694, "Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00135694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*